12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Valeant completes debt financing

Valeant Pharmaceuticals International (NYSE:VRX), Aliso Viejo, Calif.
Business: Neurology, Dermatology, Autoimmune
Date completed: 9/22/10
Type: Debt financing
Raised: $1.5 billion
Note: The financing comprises two notes....

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >